The relation between treatment benefit and underlying risk in meta-analysis

British Medical Journal

Volumn 313, Issue 7059, 1996, Pages 735-738

  Sharp, Stephen J ^a   Thompson, Simon G ^b   Altman, Douglas G ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RISK; SCLEROTHERAPY; SHORT SURVEY;

EID: 0029785769     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7059.735     Document Type: Short Survey

References (29)

1. Horowitz R. Large scale randomised evidence, large simple trials and overviews of trials: discussion - a clinician's perspective on meta-analysis. J Clin Epidemiol 1995;48:41-4.
2. Thompson SG, Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309:1351-5.
3. Chalmers T. Problems induced by meta-analysis. Statistics in Medicine 1991;10:971-80.
4. Victor N. The challenge of meta-analysis: discussion. J Clin Epidemiol 1995;48:5-8.
5. Berkey C, Hoaglin D, Mosteller F, Colditz G. A random effects regression model for meta-analysis. Statistics in Medicine 1995;14:195-411.
6. Glasziou P, Irwig L. An evidence based approach to individualising treatment. BMJ 1995;311:1356-9.
7. Davey Smith G, Egger M. Who benefits from medical interventions? BMJ 1994;308:72-4.
8. Pagliaro L, D'Amico G, Sorensen T, Lebrec D, Burroughs AK, Morabito A, et al. Prevention of first bleeding in cirrhosis - a meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992;117:59-70.
9. Bland JM, Altman DG. Regression towards the mean. BMJ 1994; 308:1499.
10. Bland JM, Altman DG. Some examples of regression to the mean. BMJ 1994;309:780.
11. Senn S. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Statistics in Medicine 1994;13:293-6.
12. Hayes R. Methods for assessing whether change depends on initial value. Statistics in Medicine 1988;7:915-27.
13. L'Abbe K, Detsky A, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987;107;224-33.
14. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford: Blackwell, 1994:288-90.
15. Yusuf A, Zucker D, Peduzzi P, Fisher L, Takaro T, Kennedy J, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70.
16. Rothwell PM. Can overall results of clinical trials be applied to all patients? Lancet 1995;345:1616-9.
17. Davey Smith G, Song F, Sheldon T. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993;206:1367-73.
18. Brand R, Kragt H. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Statistics in Medicine 1992;11:2077-82.
19. Boissel J, Collet J, Lievre M, Girard P. An effect model for the assessment of drug benefit: example of antiarrhythmic drugs in postmyocardial infarction patients. J Cardiovasc Pharmacol 1993;22:356-63.
20. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992;268:240-8.
21. Blomqvist N. On the relation between change and initial value. Journal of the American Statistical Association 1977;72:746-9.
22. Cattaneo M, Mannucci P. Desmopressin and blood loss after cardiac surgery. Lancet 1993;342:812.
23. Appel L, Miller H, Seidler A, Whelton P. Does supplementation of diet with "fish oil" reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-38.
24. Hoes AW, Grobbee DE, Lubsen J. Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertension 1995;13:805-11.
25. Egger M, Davey Smith G. Risks and benefits of treating mild hypertension: a misleading meta-analysis? J Hypertension 1995;13:813-5.
26. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346:1085-7.
27. Van Houwelingen H, Zwinderman K, Stijnen T. A bivariate approach to meta-analysis. Statistics in Medicine 1993;12:2273-84.
28. McIntosh M. The population risk as an explanatory variable in research synthesis of clinical trials. Harvard Medical School Technical Report 1995;4:1-35.
29. Cox DR, Snell EJ. Analysis of binary data. 2nd ed. London: Chapman and Hall, 1989.